| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
185,839 | 182,041 | 164,391 | 159,859 | 172,404 |
| Cost of Revenue
|
-170,657 | -168,162 | -150,824 | -149,554 | -159,878 |
|
Gross Profit
|
15,182 | 13,879 | 13,567 | 10,305 | 12,526 |
| Selling, General and Administrative Expenses
|
-3,116 | -3,406 | -8,121 | -5,898 | -7,027 |
| Depreciation, Amortization and Depletion
|
-597 | -697 | -1,019 | -1,216 | -1,523 |
| Other Income/Expense, Operating
|
-3,114 | -2,963 | -1,292 | -2,457 | -1,892 |
|
Operating Income/Expenses
|
-6,827 | -7,066 | -10,432 | -9,571 | -10,442 |
|
Total Operating Profit/Loss
|
8,355 | 6,813 | 3,135 | 734 | 2,084 |
| Total Net Finance Income/Expense
|
4,043 | 2,984 | 486 | 2,977 | 3,128 |
|
Other Income/Expense, Non-Operating
|
-7,603 | -7,186 | -6,768 | -3,225 | -3,721 |
|
Non-Operating Income/Expenses, Total
|
-3,560 | -4,202 | -6,282 | -248 | -593 |
|
Pretax Income
|
4,794 | 2,611 | -3,147 | 486 | 1,491 |
|
Provision for Income Tax
|
-629 | -303 | -1,415 | 85 | -580 |
|
Net Income from Continuing Operations
|
4,165 | 2,308 | -4,562 | 571 | 911 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,165 | 2,308 | -4,562 | 571 | 911 |
|
Non-Controlling/Minority Interests
|
0 | 0 | -730 | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
4,165 | 2,308 | -5,292 | 571 | 911 |
| Preferred/Other Stock Distribution
|
-1,551 | -1,551 | -1,125 | -- | -- |
|
Net Income Available to Common Stockholders
|
2,614 | 757 | -6,417 | 571 | 911 |
|
Diluted Net Income Available to Common Stockholders
|
2,614 | 757 | -6,417 | 571 | 911 |
| Basic EPS
|
0.18 | 0.05 | -0.39 | 0.04 | -- |
| Diluted EPS
|
0.17 | 0.04 | -0.39 | 0.04 | -- |
|
Basic Weighted Average Shares Outstanding
|
16,747 | 16,657 | 16,593 | 16,128.9990 | -- |
|
Diluted Weighted Average Shares Outstanding
|
17,189.5000 | 16,975 | 16,593 | 16,128.9990 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
751 | -373 | -3,633 | -2,491 | -1,637 |
|
EBITDA
|
1,390 | 324 | -2,614 | -1,275 | -114 |
|
Normalized EBITDA
|
2,271 | 6,500 | 6,300 | 8,400 | -32 |
|
Normalized Income
|
4,930.4075 | 2,956.1500 | -4,562 | 603.3900 | 983.6930 |
|
Total Unusual Items
|
881 | 725 | 0 | 41 | 82 |
12/31/2022 - 3/27/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade